| A/Prof Anthony White |
| QIMR Berghofer |
| Alzheimer’s disease |
| Diagnostic |
Key outcomes:
- Industry partnership with Takeda Corporation
- Research contract with GenieUS Genomics, Melbourne to develop therapeutic drugs
- Leveraged $230,000 of external funding from private philanthropic and public sources
- Partnering with Dr Lesley Cheng from LaTrobe University
- NHMRC Ideas Grant, $830,000
- US Department of Defence CDMRP-ALS Program, $880,000
“A/Prof White’s team developed a unique approach to screening drugs that target the brain’s resident immune cells (microglia) on a person-by-person basis. They are able to generate microglia from a person’s blood cells (monocytes) in two weeks at a cost of ~$50 per person.“